Evaluating tumor-infiltrating lymphocytes in hepatocellular carcinoma using hematoxylin and eosin-stained tumor sections

Figure 3 The comparison of immune^high, immune^mod and immune^low subtypes. A: Immune subtypes can predict patients’ progression-free survival. Immune^high patients had a low recurrence rate, and immune^low patients experienced a high recurrence rate; B: The median survival time for all patients divided into three categories: Immune^high (red bars), immune^mod (green bars), and immune low (purple bars); C: The incidence rate of microvascular invasion (MVI) in three immune subtypes, immune^high subtype had a lower rate of MVI compared to immune^mod and immune^low subtypes; D: The presence of neutrophils in the three immune subtypes, a high incidence of neutrophils was detected in immune^high and immune^mod subtypes. Immune^high: Tumors with high infiltrating lymphocytes in the tumor center, invasive front and peritumor; Immune^mod: Tumors other than immune^high and immune^low; Immune^low: Tumors with low infiltrating lymphocytes in the tumor center, invasive front and peritumor; PFS: Progression-free survival; MVI: Microvascular invasion.